- a method of treating a blood cancer in a human subject comprising downregulating Histone Deacetylase 3 (HDAC3) and Histone Deacetylase 8 (HDAC8), including with protein degraders
Instructions on how to participate here, whether it is to purchase tickets or register.
Gain visibility, build valuable relationships, and make a lasting impact. Partner with us to sponsor an event today